Advertisement

Advertisement

LPCN Stock Latest News

Lipocine Showcases Phase 3 Data in Postpartum Depression

Company AnnouncementsLipocine Showcases Phase 3 Data in Postpartum Depression

Lipocine Showcases Phase 3 Data for Postpartum Depression

PremiumCompany Announcements

Lipocine Showcases Phase 3 Data for Postpartum Depression

11d ago

Lipocine Showcases Pipeline at Virtual Healthcare Conference

PremiumCompany Announcements

Lipocine Showcases Pipeline at Virtual Healthcare Conference

12d ago

Lipocine Updates Corporate Presentation for Investor Communications

PremiumCompany Announcements

Lipocine Updates Corporate Presentation for Investor Communications

23d ago

LPCN Earnings this Week: How Will it Perform?

PremiumPre-Earnings

LPCN Earnings this Week: How Will it Perform?

25d ago

Lipocine Reshapes Board Leadership Amid Strategic Shift

PremiumCompany AnnouncementsLipocine Reshapes Board Leadership Amid Strategic Shift

1M ago

Lipocine price target lowered to $6 from $11 at Alliance Global

The Fly

Lipocine price target lowered to $6 from $11 at Alliance Global

2M ago

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

The Fly

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

2M ago

Lipocine weighs path after LPCN 1154 Phase 3 miss

PremiumCompany Announcements

Lipocine weighs path after LPCN 1154 Phase 3 miss

2M ago

Lipocine Updates Investor Presentation to Refine Market Messaging

PremiumCompany Announcements

Lipocine Updates Investor Presentation to Refine Market Messaging

2M ago

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

PremiumThe Fly

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

2M ago

Lipocine price target raised to $11 from $6.75 at Alliance Global

PremiumThe Fly

Lipocine price target raised to $11 from $6.75 at Alliance Global

2M ago

Lipocine Files Prospectus to Enable $50M Stock Offering

PremiumCompany AnnouncementsLipocine Files Prospectus to Enable $50M Stock Offering

3M ago

LPCN Upcoming Earnings Report: What to Expect?

Pre-Earnings

LPCN Upcoming Earnings Report: What to Expect?

3M ago

Lipocine Completes Phase 3 Trial for Postpartum Depression

Company Announcements

Lipocine Completes Phase 3 Trial for Postpartum Depression

3M ago

Lipocine Updates Investor Presentation to Reflect Latest Strategy

PremiumCompany Announcements

Lipocine Updates Investor Presentation to Reflect Latest Strategy

3M ago

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

PremiumThe Fly

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

3M ago

Lipocine price target raised to $15 from $7 at H.C. Wainwright

PremiumThe Fly

Lipocine price target raised to $15 from $7 at H.C. Wainwright

4M ago

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

PremiumCompany Announcements

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

4M ago

Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

PremiumThe FlyLipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

4M ago

Lipocine updates investor presentation and corporate materials

Company Announcements

Lipocine updates investor presentation and corporate materials

5M ago

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

Company Announcements

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >